Brief: Iconovo Signs Agreement For Development Of Inhaled Oxytocin In ICOone For Maternal Health
21/12/2020 07:08
Dec 21 (Reuters) - Iconovo AB ICO.ST :
* ICONOVO SIGNS AGREEMENT FOR DEVELOPMENT OF INHALED
OXYTOCIN IN
ICOONE FOR MATERNAL HEALTH
* ROYALTIES FROM SALES OVER A 20-YEAR PERIOD FROM LAUNCH
WILL BE
IN 5 - 10 % RANGE
Source text for Eikon: ID:nMFNjp3mc
Further company coverage: ICO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))